SCHEMBL7479621

SCHEMBL7479621

Cc1ccc(NC2CCCC2)c([N+](=O)[O-])c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 3/20 0.66
MAPT P10636 6/20 0.61
ALDH1A1 P00352 5/20 0.61
LMNA P02545 4/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
CRHBP P24387 1/20 0.61
CRHR2 Q13324 1/20 0.61
WNK1 Q9H4A3 2/20 0.59
MAPK1 P28482 2/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
HPGD P15428 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C19 P33261 1/20 0.57
L3MBTL1 Q9Y468 3/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TDP1 Q9NUW8 1/20 0.52
TP53 P04637 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13500566 0.98 HCAR3 (0.64) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL7180261 0.87 HCAR3 (0.60) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL7180257 0.87 HCAR3 (0.60) HCAR3MAPTALDH1A1LMNASMN1; SMN2
Bromide SCHEMBL11023029 0.86 HCAR3 (0.52) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL7981300 0.82 HCAR3 (0.63) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL23786250 0.82 MAPT (0.69) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL8607686 0.82 MAPT (0.69) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL17048217 0.82 HCAR3 (0.66) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL6562168 0.82 HCAR3 (0.66) HCAR3MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL3950396 0.82 HCAR3 (0.57) HCAR3MAPTALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318557-A2 QUINOLONE COMPOUND Otsuka Pharmaceutical Co., Ltd. (JP) 2018-05-09 EP disclosed
EP-1071669-A1 BICYCLIC COMPOUNDS HAVING AN ANTI-THROMBITIC EFFECT Boehringer Ingelheim Pharma KG (DE) 2001-01-31 EP disclosed
WO-1999054313-A1 BICYCLIC COMPOUNDS HAVING AN ANTI-THROMBITIC EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-28 WO disclosed